Rewalk Robotics

Research released Tuesday by the Massachusetts Technology Collaborative has found 122 companies making up the state's robotics cluster employed more than 4,700 workers and generated more than $1.6 billion in revenue in 2015.

Marlborough's ReWalk Robotics, Inc. has sold its 100th personal exoskeleton as the company looks to increasing adoption of the emerging technology.

Even though the company again lost money, placements of ReWalk Robotics' exoskeletons more than doubled in the second quarter while a German court declared the systems to be medically necessary and must be covered by insurance.

Marlborough exoskelton developer ReWalk Robotics on Tuesday announced it has teamed with the Stanford University School of Medicine to perform a regulator-mandated post-market study of its products.

Maugel Architects has completed a redesign of ReWalk Robotics' U.S. headquarters, with work done to the interior and warehouse.

The Marlborough exoskeleton maker ReWalk Robotics, Inc. has partnered with Harvard University's Wyss Institute for Biologically Inspired Engineering to develop a soft suit system to help those with stroke, multiple sclerosis (MS) and other medical issues walk again.

The U.S. Department of Veterans Affairs (VA) purchased an additional 20 ReWalk exoskeleton units from the Marlborough company to support initiation of their national multi-center clinical trial.

A new meta-study has found that 76 percent of patients involved in numerous studies of the ReWalk exoskeleton system were ultimately able to walk with no help from anyone else.

Marlborough medical device firm ReWalk Robotics on Tuesday named industry veteran Peter L. Wehrly to permanently take over the position on its nine-member board of directors held on an interim basis by an Israeli venture capitalist.

ReWalk Robotics has been on a roll recently, and now its financials can back up all the of good news coming from the company.